Clinical Trials Browser

Has results × Neuroblastoma × Bevacizumab × Clear all

NCT01114555 2019-11-21

Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma

Phase 2 Completed

34 enrolled 9 charts

Neuroblastoma

NCT01492673 2019-10-29

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Phase 2 Completed

9 enrolled 9 charts

Neuroblastoma, Sarcoma, Sarcoma, Ewing